Assenagon Asset Management S.A.
Position in PMVP — PMV Pharmaceuticals, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in PMVP
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$442,204
-$5,170 QoQ
Shares Held
330,003
-8.5% QoQ
Ownership
0.619%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 2 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $1,943,463,989 across 69 Biotechnology names. PMVP ranks #60 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
759,564 | $377,298,225 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
8,362,952 | $295,964,871 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
244,927 | $152,721,781 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
454,682 | $111,292,513 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
1,762,086 | $100,826,560 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
997,643 | $78,085,517 | |
| 7 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
124,214 | $66,696,707 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
947,495 | $59,635,335 |
All Filings in PMVP
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $442,204 | 330,003 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $447,374 | 360,786 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $175,585 | 140,468 | Shares | Sole | 2026-01-09 | |
| 2025-09-30 | $172,328 | 123,092 | Shares | Sole | 2025-10-07 | |
| 2025-06-30 | $278,842 | 263,059 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $125,391 | 115,038 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $232,088 | 153,701 | Shares | Sole | 2025-01-14 | |
| 2024-09-30 | $527,217 | 353,837 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $421,245 | 260,028 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $120,383 | 70,814 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $219,523 | 70,814 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $1,587,423 | 258,538 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $2,634,358 | 420,824 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $2,007,330 | 420,824 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $3,839,336 | 441,303 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $5,513,817 | 463,346 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $8,970,930 | 629,539 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $13,284,492 | 638,064 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $2,427,440 | 105,084 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $1,697,408 | 56,960 | Shares | Sole | 2021-10-19 | |
| 2021-06-30 | $5,618,841 | 164,486 | Shares | Sole | 2021-07-15 | |
| No filing history on record for this holder in this stock. | ||||||